Why Are Patients With Absence Seizures Absent? A Brain Imaging Study

Key facts

Sponsor

Yale University

Principal Investigator

Hal Blumenfeld, MD, PhD

Yale University

Enrollment

180 enrolled

Eligibility

6-18 years · All sexes

Timeline

2006 – 2015

Study locations (1)

• Yale University School of Medicine, Neurology Department, New Haven, Connecticut, United States

Collaborators

National Institutes of Health (NIH)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Childhood absence epilepsy

Additional recruiting or active studies for the same condition.

• RECRUITINGPHASE3NCT06315322
  A Study to Test the Long-term Safety and Tolerability of Brivaracetam in Study Participants With Childhood Absence Epilepsy or Juvenile Absence Epilepsy
  UCB Biopharma SRL
• ACTIVE NOT RECRUITINGPHASE3NCT04666610
  A Study to Evaluate the Efficacy, Safety, and Tolerability of Brivaracetam as Monotherapy in Patients 2 to 25 Years of Age With Childhood Absence Epilepsy or Juvenile Absence Epilepsy
  UCB Biopharma SRL

See all trials for Childhood absence epilepsy →